Acknowledgments GH thanks the Prince Sattam Bin Abdulaziz University (Grant No
Available at: GlaxoSmithKline Consumer Advisory
Heitzer T, Brockhoff C, Mayer B, Warnholtz A, Mollnau H, Henne S, Meinertz T, Munzel T
Optimized approach: Inject Lipo-C 30-60 minutes before morning fasted cardio
These agents include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon BCise)
Suggest pre-op review 2 to 4 weeks prior for elective cases, discontinue or adjust according to agent half-life and GI effects, target glucose and insulin-bridge plans, document explicit handoffs, and reassert nutrition and wound risk post-op